Literature DB >> 10868896

Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome.

M M Wolfe1, G Sachs.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10868896     DOI： 10.1016/s0016-5085(00)70004-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  49 in total

Review 1.  Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.

Authors:  Aaron H Mendelson; Mark Donowitz
Journal:  Dig Dis Sci       Date:  2017-08-03       Impact factor: 3.199

2.  Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

3.  Gastroprotective activity of carvacrol on experimentally induced gastric lesions in rodents.

Authors:  Irisdalva S Oliveira; Francilene V da Silva; Ana Flávia S C Viana; Márcio R V dos Santos; Lucindo J Quintans-Júnior; Maria do Carmo C Martins; Paulo H M Nunes; Francisco de A Oliveira; Rita de C M Oliveira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06-28       Impact factor: 3.000

4.  Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents.

Authors:  Mariko Teramura-Grönblad; Helka Hosia-Randell; Seija Muurinen; Kaisu Pitkala
Journal:  Scand J Prim Health Care       Date:  2010-09       Impact factor: 2.581

Review 5.  Guide to the use of proton pump inhibitors in adult patients.

Authors:  Vandana Boparai; Jaishree Rajagopalan; George Triadafilopoulos
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Balancing the risks and benefits of proton pump inhibitors.

Authors:  James M Gill; Marty S Player; David C Metz
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

7.  Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.

Authors:  Matthias Banasch; Frank Schmitz
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

8.  Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.

Authors:  Hiroshi Ichikawa; Norimasa Yoshida; Tomohisa Takagi; Naoya Tomatsuri; Kazuhiro Katada; Yutaka Isozaki; Kazuhiko Uchiyama; Yuji Naito; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

9.  Intravenous ilaprazole is more potent than oral ilaprazole against gastric lesions in rats.

Authors:  Gang Yu; Xin-Qiang Lu; Rui-Bin Su; Ze-Hui Gong; He-Zhi Xie; Hai-Tang Hu; Xue-Mei Hou
Journal:  Dig Dis Sci       Date:  2014-05-07       Impact factor: 3.199

10.  The expression of heme oxygenase-1 induced by lansoprazole.

Authors:  Tomohisa Takagi; Yuji Naito; Toshikazu Yoshikawa
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.